Clinical trial
A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions
NCT00152308 is registered in ClinicalTrials.gov with Translumina GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions
- Lead sponsor
- Translumina GmbH
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- December 31, 2004
- Completion date
- February 28, 2007
- Enrollment
- 333 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.